These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23612993)

  • 1. Preclinical safety evaluation.
    Holt JD; Nuttall JP
    Curr Top Microbiol Immunol; 2014; 383():55-78. PubMed ID: 23612993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and pharmacology trial.
    Mauck C; Thurman A; Schwartz J
    Curr Top Microbiol Immunol; 2014; 383():79-95. PubMed ID: 24173586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbicides for prevention of HIV infection: clinical efficacy trials.
    Abdool Karim SS; Baxter C
    Curr Top Microbiol Immunol; 2014; 383():97-115. PubMed ID: 23695725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicide dosage forms.
    Rohan LC; Devlin B; Yang H
    Curr Top Microbiol Immunol; 2014; 383():27-54. PubMed ID: 24220751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate microbicides and their mechanisms of action.
    Herrera C; Shattock RJ
    Curr Top Microbiol Immunol; 2014; 383():1-25. PubMed ID: 23612992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New HIV drugs show promise in early studies.
    McCarthy M
    Lancet; 2002 Mar; 359(9308):767. PubMed ID: 11888592
    [No Abstract]   [Full Text] [Related]  

  • 8. Rectal microbicide development.
    McGowan I; Dezzutti C
    Curr Top Microbiol Immunol; 2014; 383():117-36. PubMed ID: 23612991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of dapivirine vaginal ring for HIV prevention.
    Devlin B; Nuttall J; Wilder S; Woodsong C; Rosenberg Z
    Antiviral Res; 2013 Dec; 100 Suppl():S3-8. PubMed ID: 24188702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.
    Pirrone V; Wigdahl B; Krebs FC
    Antiviral Res; 2011 Jun; 90(3):168-82. PubMed ID: 21439325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application studies of animal models in evaluating safety and efficacy of HIV-1 microbicides].
    Zhu L; Zhang GH; Zheng YT
    Dongwuxue Yanjiu; 2010 Feb; 31(1):66-76. PubMed ID: 20446456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
    Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
    Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improved long-term success. New nucleoside for once daily combinations].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():31-3. PubMed ID: 15373043
    [No Abstract]   [Full Text] [Related]  

  • 15. FAITH - Fast Assembly Inhibitor Test for HIV.
    Hadravová R; Rumlová M; Ruml T
    Virology; 2015 Dec; 486():78-87. PubMed ID: 26410239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 19. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization.
    Ndesendo VM; Choonara YE; Meyer LC; Kumar P; Tomar LK; Tyagi C; du Toit LC; Pillay V
    Drug Dev Ind Pharm; 2015; 41(8):1274-87. PubMed ID: 25109400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.